跳至主要内容
临床试验/CTRI/2025/10/096575
CTRI/2025/10/096575尚未招募不适用

Distribution of lymph node metastasis in Carcinoma Esophagus

DR. Anil K Bhatt1 个研究点 分布在 1 个国家目标入组 81 人开始时间: 2025年11月10日最近更新:

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
81
试验地点
1
主要终点
Clinical distribution of lymph node metastasis in thoracic esophageal SCC.

研究概览

简要总结

The survival rate following esophageal resection is a median of 25 - 74 months, and an important parameter for survival is lymph node status. The distribution of lymph node metastasis depends on tumor characterestics such as location, histology, T stage, and neoadjuvant treatment. If a distribution pattern of lymph node metastasis of esophageal carcinoma can be identified, optimal neoadjuvant and surgical treatment can be determined.

研究设计

研究类型
Observational

入排标准

年龄范围
18.00 Year(s) 至 99.00 Year(s)(—)
性别
All

入选标准

  • 1.Primary scc of thoracic esophagus.
  • mid and lower 2.Surgically resectable tumor ( cT1-4a, N0-3, M0 ).

排除标准

  • Previous esophageal surgery.

结局指标

主要结局

Clinical distribution of lymph node metastasis in thoracic esophageal SCC.

时间窗: At the time of presentation to OPD

次要结局

  • Lymph node yield and lymph node metastasis as per lymph node station in patients who are treated with or without NACT, post surgery(At the time of definitive surgery)

研究者

发起方
DR. Anil K Bhatt
申办方类型
Private medical college
责任方
Principal Investigator
主要研究者

Dr Neethu Tomy

KMC Manipal

研究点 (1)

Loading locations...

相似试验